Skip to main content

Crowley Michael

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Crowley Michael as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Mar 18, 2025 (view filing)Mar 144 daysCrowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−3.00K$247.06−$741.2K−26.9%8.17K after
Jun 14, 2024 (view filing)Jun 131 dayCrowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−369$281.91−$104.0K−5.3%6.57K after
Feb 28, 2024 (view filing)Feb 271 dayCrowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−3.00K$336.00−$1.01M−30.2%6.94K after
Nov 28, 2023 (view filing)Nov 28Same dayCrowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−642$305.10−$195.9K−8.5%6.94K after
Jun 16, 2023 (view filing)Jun 151 dayCrowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−500$379.39−$189.7K−7.6%6.04K after
Aug 10, 2021 (view filing)Aug 91 dayCrowley MichaelEVP, GBL Commercial OperationsSSaleBio-Rad A Common Stock−3.00K$754.93−$2.26M−45.0%3.67K after2 lots